COVID-19 (severe/critical) |
Comorbidities |
Heart disease [Present vs. Not present] |
Odds ratio: 2.760 (1.390-5.450)
|
Xu
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Heart disease [Present vs. Not present] |
Odds ratio: 2.700 (1.520-4.800)
|
Jain
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Hypertension [Present vs. Not present] |
Odds ratio: 2.870 (2.090-3.930)
|
Matsushita
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Hypertension [Present vs. Not present] |
Odds ratio: 2.060 (1.610-2.620)
|
Ma
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Hypertension [Present vs. Not present] |
Odds ratio: 1.970 (1.400-2.770)
|
Jain
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Hypertension [Present vs. Not present] |
Odds ratio: 2.030 (1.540-2.680)
|
Li
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Gender [Male vs. Female] |
Odds ratio: 1.730 (1.500-2.010)
|
Matsushita
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Gender [Male vs. Female] |
Odds ratio: 1.350 (1.200-1.520)
|
Ma
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Gender [Male vs. Female] |
Odds ratio: 1.150 (0.890-1.480)
|
Jain
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Overweight/obesity [Present vs. Not present] |
Odds ratio: 3.380 (0.070-6.690)
|
Xu
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Smoking [Present vs. Not present] |
Odds ratio: 1.770 (0.780-4.020)
|
Matsushita
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Smoking [Present vs. Not present] |
Odds ratio: 1.450 (1.030-2.040)
|
Alqahtani
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Smoking [Present vs. Not present] |
Odds ratio: 1.400 (0.980-2.000)
|
Vardavas
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Smoking [Present vs. Not present] |
Odds ratio: 1.730 (1.150-2.630)
|
Ma
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Diabetes [Present vs. Not present] |
Odds ratio: 2.670 (1.910-3.740)
|
Chen
|
|
|
COVID-19 (death) |
Patient characteristics |
Gender [Male vs. Female] |
Odds ratio: 2.360 (1.150-4.830)
† |
Jin
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Heart disease [Present vs. Not present] |
Odds ratio: 2.850 (1.680-4.840)
|
Chen
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Cancer [Present vs. Not present] |
Odds ratio: 0.890 (0.280-2.810)
† |
Mao
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Hypertension [Present vs. Not present] |
Odds ratio: 2.300 (1.760-3.000)
|
Chen
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Diabetes [Present vs. Not present] |
Odds ratio: 1.520 (0.700-3.300)
† |
Mao
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Smoking [Present vs. Not present] |
Odds ratio: 1.690 (0.410-6.920)
|
Lippi
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Diabetes [Present vs. Not present] |
Odds ratio: 4.570 (1.460-14.280)
† |
Wang
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Diabetes [Present vs. Not present] |
Odds ratio: 4.580 (1.970-10.660)
† |
Qi
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Heart disease [Present vs. Not present] |
Odds ratio: 2.760 (1.030-7.350)
† |
Wang
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Hypertension [Present vs. Not present] |
Odds ratio: 10.540 (3.940-28.170)
† |
Qi
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Hypertension [Present vs. Not present] |
Odds ratio: 0.320 (1.670-6.180)
† |
Mao
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Overweight/obesity [Present vs. Not present] |
Odds ratio: 4.890 (2.190-10.870)
† |
Qi
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Hypertension [Present vs. Not present] |
Odds ratio: 5.090 (2.260-11.480)
† |
Wang
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
COPD [Present vs. Not present] |
Odds ratio: 3.370 (1.410-8.030)
† |
Qi
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Gender [Male vs. Female] |
Odds ratio: 1.930 (1.110-3.370)
† |
Mao
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Smoking [Present vs. Not present] |
Odds ratio: 14.460 (7.030-29.750)
† |
Qi
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Cancer [Present vs. Not present] |
Odds ratio: 1.140 (0.670-1.910)
|
Petrilli
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Chronic kidney disease [Present vs. Not present] |
Odds ratio: 0.510 (0.290-0.890)
|
Petrilli
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Diabetes [Present vs. Not present] |
Odds ratio: 1.140 (0.830-1.580)
|
Petrilli
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Heart disease [Present vs. Not present] |
Odds ratio: 0.890 (0.550-1.410)
|
Petrilli
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Heart failure [Present vs. Not present] |
Odds ratio: 1.310 (0.730-2.340)
|
Petrilli
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Hypertension [Present vs. Not present] |
Odds ratio: 0.950 (0.680-1.330)
|
Petrilli
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Gender [Male vs. Female] |
Odds ratio: 0.990 (0.740-1.330)
|
Petrilli
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Overweight/obesity [Present vs. Not present] |
Odds ratio: 1.380 (1.030-1.850)
|
Petrilli
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Age [1 year increase vs. Not applicable] |
Odds ratio: 1.040 (1.010-1.170)
§ |
Xiaochun
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Cerebrovascular disease [Present vs. Not present] |
Odds ratio: 2.480 (1.140-5.400)
|
Xiaochun
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Heart disease [Present vs. Not present] |
Odds ratio: 1.050 (1.060-1.080)
|
Xiaochun
|
|
|
COVID-19 (severe/critical) |
Patient characteristics |
Age [1 year increase vs. Not applicable] |
Odds ratio: 1.060 (1.020-1.090)
|
Chen
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Diabetes [Present vs. Not present] |
Odds ratio: 2.480 (0.820-7.460)
† |
Wang
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Diabetes [Present vs. Not present] |
Odds ratio: 1.300 (0.470-3.590)
† |
Zhang
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Heart disease [Present vs. Not present] |
Odds ratio: 13.670 (3.140-59.530)
|
Chen
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Heart disease [Present vs. Not present] |
Odds ratio: 16.610 (2.290-120.580)
§ |
Chen
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Heart disease [Present vs. Not present] |
Odds ratio: 8.780 (2.460-31.260)
† |
Cao
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Hypertension [Present vs. Not present] |
Odds ratio: 3.640 (1.480-8.960)
|
Chen
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Hypertension [Present vs. Not present] |
Odds ratio: 1.830 (0.650-5.160)
† |
Cao
|
|
|